Peritoneal Metastasis Center
Kishiwada Tokushukai Hospital, Osaka
Peritoneal metastasis from gastric cancer has long been considered a difficult condition to treat.
Its management has evolved over time through clinical practice and academic work in this field.
Yutaka Yonemura, M.D., Ph.D.
米村 豊
Director, Peritoneal Metastasis Center
Dr. Yutaka Yonemura has worked in peritoneal surface oncology, focusing on gastric cancer with peritoneal metastasis.
His work includes intraperitoneal chemotherapy, HIPEC, and cytoreductive surgery.
Selected Publications
Effects of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion for Patients with Peritoneal Metastasis from Gastric Cancer
Effects of neoadjuvant intraperitoneal/systemic chemotherapy (NIPS) in patients with gastric cancer with peritoneal metastasis
Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by bidirectional chemotherapy prior to cytoreductive surgery and HIPEC
Long term survival after cytoreductive surgery combined with perioperative chemotherapy in gastric cancer patients with peritoneal metastases
Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal metastases from gastric cancer: a multi-institutional cohort study (PSOGI)
History of peritoneal surface malignancy treatment in Japan
All cases require individual assessment.